The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema
about
The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia.Adsorption of surfactant protein D from human respiratory secretions by carbon nanotubes and polystyrene nanoparticles depends on nanomaterial surface modification and sizeEfficient protein production inspired by how spiders make silkSurfactant protein D inhibits HIV-1 infection of target cells via interference with gp120-CD4 interaction and modulates pro-inflammatory cytokine production.Surfactant protein D in human lung diseases.Comparative evaluation of heterologous production systems for recombinant pulmonary surfactant protein D.Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient miceCollectins and cationic antimicrobial peptides of the respiratory epithelia.Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature.Alveolar surfactant protein D content modulates bleomycin-induced lung injury.Delivery and performance of surfactant replacement therapies to treat pulmonary disorders.Surfactant proteins A and D in pulmonary diseases of preterm infants.Effect of carbon dioxide on neonatal mouse lung: a genomic approach.HIV Infection and Circulating Levels of Prosurfactant Protein B and Surfactant Protein D.
P2860
Q24816691-DDDFDCF0-AEA9-4338-9E2D-3302F4EA112CQ28384891-8569273A-9BEC-460E-A395-A222F5090CE1Q30854561-1A8F73B4-B823-4869-9367-A1B6632C124EQ33921367-C04F870F-EEAB-455F-8227-9BFD2DCD2835Q34567354-8F64C9D0-D00E-4387-8B53-258AC0206ABFQ34652077-099EF0C3-9761-4AD2-B002-2B68FBD2DBC4Q36145590-4100716F-BF8A-4793-A918-2E8E2BE9E3F0Q36590997-246332DA-6233-4FAD-B471-423B04198F9AQ37095685-B13A6921-F0B1-4D8B-B23D-7FD68722549DQ37282586-86C2BD9F-8F0E-41AD-A738-9B9D6C168DC3Q37341712-C8B6ABE3-96EC-4D78-9B0A-7F61BA5CF4E0Q38018982-8E0FAFC5-BCA4-4774-9861-546381F6312EQ43577928-16FE4AFB-3FD0-4FE4-9DEE-52DF132F75A5Q47260481-B66E402C-6602-442A-AF90-F8CD90990112
P2860
The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The potential of recombinant s ...... cystic fibrosis, and emphysema
@ast
The potential of recombinant s ...... cystic fibrosis, and emphysema
@en
type
label
The potential of recombinant s ...... cystic fibrosis, and emphysema
@ast
The potential of recombinant s ...... cystic fibrosis, and emphysema
@en
prefLabel
The potential of recombinant s ...... cystic fibrosis, and emphysema
@ast
The potential of recombinant s ...... cystic fibrosis, and emphysema
@en
P2860
P356
P1476
The potential of recombinant s ...... cystic fibrosis, and emphysema
@en
P2860
P304
P356
10.1136/ADC.88.11.981
P407
P577
2003-11-01T00:00:00Z